Research & Development Market Research Reports & Industry Analysis
Bringing R&D costs and times down, therefore, means there are many opportunities to improve efficiencies, advance technological innovation, and economize and optimize. The pharmaceutical R&D category tracks both drug pipeline reports, competitive R&D strategies, and markets important and ancillary to the research efforts themselves, including activities in the biotech and sector that impinge upon the process.
Research & Development Industry Research & Market Reports
-
Global Organ Care Products Market Databank
... to 2029. Kidney segment is expected to be the highest contributor to this market, with $39.6 Million in 2020, and is anticipated to reach $54.3 Million by 2029, registering a CAGR of 3.63%. Lungs segment ... Read More
-
North America Organ Care Products Market Databank
... 2021 to 2029. Kidney segment is expected to be the highest contributor to this market, with $39.6 Million in 2020, and is anticipated to reach $54.3 Million by 2029, registering a CAGR of 3.63%. Lungs ... Read More
-
Leading Organ Care Products Product Type Markets Databank
... from 2021 to 2029. Trolly segment is expected to be the highest contributor to this market, with $61.2 Million in 2020, and is anticipated to reach $84.4 Million by 2029, registering a CAGR of 3.66%. ... Read More
-
Leading Synthetic Biology Country Markets Databank
... 2029. Europe is expected to be the highest contributor to this market, with $2,578.3 Million in 2020, and is anticipated to reach $3,088.7 Million by 2029, registering a CAGR of 2.06%. Asia-Pacific is anticipated to ... Read More
-
Latin America, Middle East & Africa Synthetic Biology Market Databank
... 3.06% from 2021 to 2029. Rotator Cuff Repair segment is expected to be the highest contributor to this market, with $2,169.8 Million in 2020, and is anticipated to reach $2,843.7 Million by 2029, registering a ... Read More
-
Europe Synthetic Biology Market Databank
... Rotator Cuff Repair segment is expected to be the highest contributor to this market, with $2,169.8 Million in 2020, and is anticipated to reach $2,843.7 Million by 2029, registering a CAGR of 3.09%. Epicondylitis segment ... Read More
-
Leading Organ Care Products Country Markets Databank
... 2021 to 2029. North America is expected to be the highest contributor to this market, with $41.9 Million in 2020, and is anticipated to reach $55.0 Million by 2029, registering a CAGR of 3.10%. Asia-Pacific ... Read More
-
North America Synthetic Biology Market Databank
... 2029. Rotator Cuff Repair segment is expected to be the highest contributor to this market, with $2,169.8 Million in 2020, and is anticipated to reach $2,843.7 Million by 2029, registering a CAGR of 3.09%. Epicondylitis ... Read More
-
Asia-Pacific Synthetic Biology Market Databank
... Rotator Cuff Repair segment is expected to be the highest contributor to this market, with $2,169.8 Million in 2020, and is anticipated to reach $2,843.7 Million by 2029, registering a CAGR of 3.09%. Epicondylitis segment ... Read More
-
Latin America, Middle East & Africa Organ Care Products Market Databank
... CAGR of 3.62% from 2021 to 2029. Kidney segment is expected to be the highest contributor to this market, with $39.6 Million in 2020, and is anticipated to reach $54.3 Million by 2029, registering a ... Read More
-
Europe Organ Care Products Market Databank
... to 2029. Kidney segment is expected to be the highest contributor to this market, with $39.6 Million in 2020, and is anticipated to reach $54.3 Million by 2029, registering a CAGR of 3.63%. Lungs segment ... Read More
-
Leading Organ Care Products Organ Type Markets Databank
... from 2021 to 2029. Kidney segment is expected to be the highest contributor to this market, with $39.6 Million in 2020, and is anticipated to reach $54.3 Million by 2029, registering a CAGR of 3.63%. ... Read More
-
Leading Synthetic Biology Application Markets Databank
... 2029. Rotator Cuff Repair segment is expected to be the highest contributor to this market, with $2,169.8 Million in 2020, and is anticipated to reach $2,843.7 Million by 2029, registering a CAGR of 3.09%. Epicondylitis ... Read More
-
2022 Global Biosensors Industry (2028 Outlook)
... market size data for a three-year historical trend (2016-2019), a three-year forecast estimate trends (2020-2023), and a five-year outlook projection (2023-2028) for 46 countries. Market and product shipments include the total value of all products ... Read More
-
Asia-Pacific Organ Care Products Market Databank
... to 2029. Kidney segment is expected to be the highest contributor to this market, with $39.6 Million in 2020, and is anticipated to reach $54.3 Million by 2029, registering a CAGR of 3.63%. Lungs segment ... Read More
-
Organ-on-a-Chip: Global Markets
... segments. Revenue forecasts from 2019 to 2026 are given for each type, application, offering and end user. Revenue generated from the installation and maintenance of instruments has been excluded from the report. The application segment ... Read More
-
Global Recombinant Proteins Market Size study, By Product (Antibodies, Hormones, Growth Factors, Enzyme, Cytokines, Others), By Application (Drug Discovery & Development, Biopharmaceutical Production, Biotechnology Research, Academic Research Studies, Other Applications), By End User (Pharmaceutical & Biopharmaceutical Companies, Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Other End Users), and Regional Forecasts 2022-2028
... Biopharmaceutical Companies, Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Other End Users), and Regional Forecasts 2022-2028 Global Recombinant Proteins Market is valued approximately USD 910 million in 2021 and is anticipated to grow with ... Read More
-
Mice Model Market (Product Type: Transgenic Mice Model, Hybrid/Congenic Mice Model, Knockout Mice Model, Carcinogen-induced & Spontaneous Mice Model, Outbred Mice Model, Inbred Mice Model, Transplantation Mice Model, and Conditioned/Surgically Modified Mice Model; Specialty: Immunology, Central Nervous System [CNS], Oncology, Cardiovascular, Diabetes, and Metabolism & Regulation; and Service: Breeding & Rederivation Services, Cryopreservation & Cryorecovery Services, Quarantine Services, Genetic Testing Services, Model In-licensing Services, In Vivo & In Vitro Pharmacology Services, Genetically Engineered Model Services, and Other Services [Surgical and Line Rescue]) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028
... Central Nervous System [CNS], Oncology, Cardiovascular, Diabetes, and Metabolism & Regulation; and Service: Breeding & Rederivation Services, Cryopreservation & Cryorecovery Services, Quarantine Services, Genetic Testing Services, Model In-licensing Services, In Vivo & In Vitro Pharmacology ... Read More
-
Cell Line Development Market Research Report Forecast till 2027
... by the end of 2027. Cell Line Development is used for drug target recognition and production of biologic drugs. These cell line development methods are used in Cell surface expression screening, Cell viability, Clone productivity ... Read More
-
Global Synthetic Biology Market 2022-2028
... improvements in healthcare. According to latest analysis by Gen Consulting Company, the global synthetic biology market is projected to climb to USD 39,579 million by 2028-end, progressing at a CAGR of 19.7% during 2022-2028. The ... Read More
-
Global Autoimmune Disease Therapeutics Market: Analysis By Drug Class (Anti-inflammatory, Interferons, NSAIDs and Antihyperglycemics) By Indication (Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Disease, Type 1 Diabetes) By Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America) Size & Trends with Impact of Covid-19 and Forecast up to 2025
... & Africa, and Latin America) Size & Trends with Impact of Covid-19 and Forecast up to 2025 Scope of the Report The report provides an in depth analysis of the global autoimmune disease therapeutics market ... Read More
-
eClinical solutions Market Size By Solution (Randomization and Trial Supply Management (RTSM), Clinical Data Management System (CDMS), Clinical Trial Management System (CTMS), Electronic Clinical Outcome Assessment (eCOA), Electronic Trial Master Files (ETMF), Electronic Data Capture (EDC)), By Delivery Mode (Licensed Enterprise (On-premise) solutions, Cloud-based (SAAS) solutions, Web-hosted (On-demand) solutions), By Clinical Trial Phase (Phase I, Phase II, Phase III, Phase IV), By End-use (Contract Research Organizations (CROs), Medical Device Companies, Pharma/Biotech Companies, Hospitals & Clinics), Industry Analysis Report, Regional Outlook, Application Potential, Covid-19 Impact Analysis, Competitive Market Share & Forecast, 2022 - 2028
... (EDC)), By Delivery Mode (Licensed Enterprise (On-premise) solutions, Cloud-based (SAAS) solutions, Web-hosted (On-demand) solutions), By Clinical Trial Phase (Phase I, Phase II, Phase III, Phase IV), By End-use (Contract Research Organizations (CROs), Medical Device Companies, ... Read More
-
2022 Global: In Vitro Fertilization - Innovative Markets Forecast (2028) report
... 2017 through 2028. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2017 to 2028 using regression ... Read More
-
2022 Global: Human Liver Models - Innovative Markets Forecast (2028) report
... 2017 through 2028. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2017 to 2028 using regression ... Read More
-
2022 Global: In Vivo Toxicology - Innovative Markets Forecast (2028) report
... 2017 through 2028. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2017 to 2028 using regression ... Read More
Research Assistance
